| 标题 |
 Abstract CT204: Phase 1a/b study of runimotamab, a HER2 x CD3 T cell-engaging bispecific antibody, administered as a single agent and in combination with trastuzumab in patients with HER2-expressing breast cancer (BC) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Cancer Research 作者：Shanu Modi; Timothy A. Yap; Tira J. Tan; Armando Santoro; Valentina Gambardella; et al 出版日期：2025-04-25 需要原始海报，不需要摘要，谢谢 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
学术文献互助
贪玩的秋柔
YifanWang
殷勤的紫槐
chandangfo
无极微光
碧蓝傲蕾
Singularity
云飞扬
Criminology34
OsamaKareem
7749
Rita
乐空思
大力的灵雁
MP
arniu2008
ablerHope
LaTeXer
皖公网安备34019202002308
